$150k Goal Reached and New Goal Announced

On Giving Tuesday—Nov. 28, 2023—Matt and Michele Herndon (Prez and VPrez of The M&FF) mailed off the final installment of a $150k commitment to research into Mitchell Syndrome and possible treatments. Thanks to ALL who made reaching this goal possible. Of that $150k, $100k went to The Miller Lab at Washington University, where they are taking promising steps towards developing an ASO (antisense oligonucleotide) treatment for Mitchell Syndrome. And $50k went to the lab of Dr. Hyunglok Chung at Houston Methodist Hospital, who is researching the effects of riboflavin on Mitchell Syndrome patients.

We also announced NEW FUNDRAISING GOALS. We’d like to raise an additional $120k by the end of 2024—$100k to continue the research, and $20k for patient support and increasing awareness of Mitchell Syndrome. We are a long way away from treatments and cures, but every dollar raised is a step in the right direction.